About PeriRx
PeriRx is a company based in Broomall (United States) founded in 2008 by Stephen Swanick. PeriRx operates in a competitive market with competitors including Veracyte, Viome Life Sciences, HAYA Therapeutics, Cajal Neuroscience and Cofactor Genomics, among others.
- Headquarter Broomall, United States
- Founders Stephen Swanick
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PeriRx
Detailed funding history for PeriRx
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PeriRx
Investment portfolio details for PeriRx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PeriRx
Detailed financials for PeriRx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Perirx Comparisons
Peer comparison for PeriRx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PeriRx
PeriRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Veracyte, Viome Life Sciences, HAYA Therapeutics, Cajal Neuroscience and Cofactor Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are developed.
|
|
| Locked | Locked | Locked |
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
|
|
| Locked | Locked | Locked |
RNA-based therapies for treating heart diseases are developed.
|
|
| Locked | Locked | Locked |
Neurodegenerative disease drugs are developed through genetic screening and multi-omics.
|
|
| Locked | Locked | Locked |
Diagnostic assays are developed using RNA sequencing technology.
|
|
| Locked | Locked | Locked |
Solutions for early oral cancer detection are developed and provided.
|
Detailed competitors of PeriRx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Perirx
Complete news archive for PeriRx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PeriRx
PeriRx was founded in 2008.
PeriRx is headquartered in Broomall, United States. It is registered at Broomall, Pennsylvania, United States.
Stephen Swanick is the current CEO of PeriRx. They have also founded this company.
PeriRx was founded in 2008 and is based in Broomall, United States, within the diagnostics sector. Saliva-based risk stratification tests for oral cancer are developed, with the initial product, SaliMark OSCC, utilized by clinicians for suspicious lesions where samples are shipped to company labs for analysis. Additional early detection tests for lung cancer, Sjögrens Syndrome, type 1 and 2 diabetes, and periodontal disease are being developed using licensed UCLA technology.
PeriRx's top competitors include Viome Life Sciences, HAYA Therapeutics and Veracyte.